Fairmount Funds Management LLC / VRDN
Fairmount Funds Management LLC’s Viridian Therapeutics Inc Position
Does Fairmount Funds Management LLC own Viridian Therapeutics Inc (VRDN)? Yes — 3.91M shares worth $77M (+5.53% of its 13F portfolio) as of Q1 2026.
Position Value
$77M
Q1 2026
Shares
3.91M
% of Portfolio
+5.53%
Quarters Held
21
currently held
Position History VRDN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 3.91M | $77M | +5.53% |
| Q4 2025 | 3.91M | $122M | +9.27% |
| Q3 2025 | 3.46M | $75M | +6.72% |
| Q2 2025 | 3.46M | $48M | +6.27% |
| Q1 2025 | 3.45M | $46M | +7.21% |
| Q4 2024 | 3.45M | $66M | +6.57% |
| Q3 2024 | 3.45M | $78M | +6.36% |
| Q2 2024 | 1.85M | $24M | +2.71% |
| Q1 2024 | 1.85M | $32M | +3.52% |
| Q4 2023 | 1.37M | $30M | +3.15% |
| Q3 2023 | 1.37M | $21M | +2.53% |
| Q2 2023 | 1.37M | $33M | +4.59% |
| Q1 2023 | 1.37M | $35M | +5.99% |
| Q4 2022 | 1.37M | $40M | +6.35% |
| Q3 2022 | 1.37M | $28M | +4.94% |
| Q2 2022 | 944.1K | $11M | +2.50% |
| Q1 2022 | 944.1K | $17M | +4.13% |
| Q4 2021 | 944.1K | $19M | +6.15% |
| Q3 2021 | 944.1K | $16M | +5.65% |
| Q2 2021 | 35.1K | $642,000 | +0.26% |
| Q1 2021 | 35.1K | $581,000 | +0.24% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fairmount Funds Management LLC’s full portfolio or all institutional holders of VRDN.